Abstract:AIM:To study Hepatitis B virus (HBV) infection and its association with hepatocellular carcinoma (HCC) at the miRNA level.METHODS:Three cellular models were used to investigate miRNA expression changes during HBV infection: human HepG2 hepatoblastoma cell line as a model without HBV infection; HepG2 cell line transfected with a 1.3-fold full-length HBV genome as an acute infection model; and HepG2.2.15 cell line, which is derived from HepG2 and stably transfected with a complete HBV genome, as a chronic infection model. The miRNA levels were examined using microarray technology. To explore the relationship between HBV infection and HCC genesis at the miRNA level, we downloaded from national center for biotechnology information Gene Expression Omnibus an miRNA expression dataset derived from HCC patients, most of whom are HBV carriers. We compared the miRNA expression alterations during HBV infection with those in HCC patients, by analyzing miRNA expression change profiles statistically.RESULTS:Seventy-seven and 48 miRNAs were differentially expressed during acute and chronic HBV infection, respectively. Among these miRNAs, 25 were in common, the intersection of which was significant under the hypergeometric test (P = 1.3 × 10⁻¹¹). Fourteen miRNAs were observed to change coherently in the acute and chronic infections, with one upregulated and 13 downregulated. Eleven showed inverse changes during the two phases of infection; downregulated in the acute infection and upregulated in the chronic infection. The results imply that common and specific mechanisms exist at the miRNA level during acute and chronic HBV infection. Besides, comparative analysis of the miRNA expression changes during HBV infection with those in HCC indicates that, although miRNA expression changes during HBV infection are distinct from those in HCC patients (P < 2.2 × 10⁻¹⁶), they exhibited significant correlations (P = 0.0229 for acute infection; P = 0.0084 for chronic infection). Perturbation of miRNA expression during chronic HBV infection was closer to that in HCC patients than that during acute HBV infection. This observation implies the contribution of miRNAs to HCC genesis from HBV infection. According to their patterns of differential expression in acute and chronic HBV infection, as well as in HCC, miRNAs of potential research interest could be identified, such as miR-18a/miR-18b, miR-106a, miR-221 and miR-101. For instance, the gradient expression alteration of miR-221 in the above three phases, which is downregulated in acute HBV infection, normally expressed in chronic HBV infection, and upregulated in HCC, indicates that it may be a key effector for progression of the disease.CONCLUSION:Our analysis provides insights into HBV infection and related HCC in relation to miRNAs, and reveals some candidate miRNAs for future studies.

ACE2 and TMPRSS2 Expression in Hepatocytes of Chronic HBV Infection Patients

Clinical Significance of Herpes Virus Entry Mediator Expression in Hepatitis B Virus-Related Hepatocellular Carcinoma.

Clinical Significance and Molecular Mechanism of Angiotensin-Converting Enzyme 2 in Hepatocellular Carcinoma Tissues

Epidemiological and Clinical Characteristics of 70 Cases of Coronavirus Disease and Concomitant Hepatitis B Virus Infection: A Multicentre Descriptive Study

Tissue Transglutaminase 2 Exerts a Tumor-Promoting Role in Hepatitis B Virus-Related Hepatocellular Carcinoma.

A profiling analysis on the receptor ACE2 expression reveals the potential risk of different type of cancers vulnerable to SARS-CoV-2 infection

Effects of HBeAg and HBsAg on cytokine excretion and angiotensin-converting enzyme activity in HepG<sub>2</sub> cell line

Hepatitis B Virus and Hepatitis C Virus Play Different Prognostic Roles in Intrahepatic Cholangiocarcinoma: A Meta-Analysis.

Significance of Hepatitis B Virus Surface Antigen, Hepatitis C Virus Expression in Hepatocellular Carcinoma and Pericarcinomatous Tissues.

LIVER METASTASES FROM COLORECTAL CANCER WERE MORE SUSCEPTIBLE TO COVID-19

Hepatitis B Virus (HBV) Receptors: Deficiency in Tumor Results in Scant HBV Infection and Overexpression in Peritumor Leads to Higher Recurrence Risk.

Hepatitis B Virus and Hepatocellular Carcinoma at the Mirna Level.

Evaluation of COVID-19 Based on ACE2 Expression in Normal and Cancer Patients

Specific ACE2 Expression in Cholangiocytes May Cause Liver Damage After 2019-nCoV Infection

Different Expression of Hepatitis B Surface Antigen Between Hepatocellular Carcinoma and Its Surrounding Liver Tissue, Studied Using a Tissue Microarray

Coinfection of Clonorchis Sinensis and Hepatitis B Virus: Clinical Liver Indices and Interaction in Hepatic Cell Models.

[Expression of IFN-alpha/beta Receptor in the PBMCs and Liver of Patients with Hepatitis B and Its Clinical Significance].

Human hepatocytes express absent in melanoma 2 and respond to hepatitis B virus with interleukin-18 expression

Activation of AIM2 by Hepatitis B Virus Results in Antiviral Immunity That Suppresses Hepatitis C Virus During Coinfection.

Hepatitis B Virus Infection Promotes Hepatocellular Carcinoma Progression Through LPC/ENPP2/LPA Axis

[Hepatitis B virus down-regulates the expression of inhibin and promotes the proliferation and survival of hepatocellular carcinoma cells]